Patents by Inventor Rick G. Schnellmann

Rick G. Schnellmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5HT1F receptor agonists and mitochondrial biogenesis
    Patent number: 11939301
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.
    Type: Grant
    Filed: April 23, 2021
    Date of Patent: March 26, 2024
    Assignees: MUSC Foundation for Research Development, The United States Government as Represented by the Department of Veterans Affairs
    Inventors: Christopher C. Lindsey, Craig C. Beeson, Yuri Karl Peterson, Rick G. Schnellmann
  • COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICAL AGENTS
    Publication number: 20230225998
    Abstract: Provided herein are compositions and methods for delivering pharmaceutical agents. In particular, provided herein are hydrogel formulations of suramin for use in wound healing, wound prevention, and other applications.
    Type: Application
    Filed: June 11, 2021
    Publication date: July 20, 2023
    Inventors: Heidi M. Mansour, Rick G. Schnellmann, David Encinas
  • Compositions and methods for delivering pharmaceutical agents
    Patent number: 11110060
    Abstract: Provided herein are compositions and methods for wound healing. In particular, provided herein are spray dried suramin for use in wound healing and other applications.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: September 7, 2021
    Assignee: Arizona Board of Regents on Behalf of the University of Arizona
    Inventors: Heidi M. Mansour, Rick G. Schnellmann, Maria F. Acosta
  • 5HT1F RECEPTOR AGONISTS AND MITOCHONDRIAL BIOGENESIS
    Publication number: 20210238147
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.
    Type: Application
    Filed: April 23, 2021
    Publication date: August 5, 2021
    Inventors: Christopher C. LINDSEY, Craig C. BEESON, Yuri Karl PETERSON, Rick G. SCHNELLMANN
  • 5HT1F receptor agonists and mitochondrial biogenesis
    Patent number: 11014892
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: May 25, 2021
    Assignees: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT, The United States Government as Represented by the DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Christopher C. Lindsey, Craig C. Beeson, Yuri Karl Peterson, Rick G. Schnellmann
  • COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICAL AGENTS
    Publication number: 20200306190
    Abstract: Provided herein are compositions and methods for wound healing. In particular, provided herein are spray dried suramin for use in wound healing and other applications.
    Type: Application
    Filed: October 25, 2018
    Publication date: October 1, 2020
    Inventors: Heidi M. Mansour, Rick G. Schnellmann, Maria F. Acosta
  • 5HT1F RECEPTOR AGONISTS AND MITOCHONDRIAL BIOGENESIS
    Publication number: 20200055827
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.
    Type: Application
    Filed: November 2, 2017
    Publication date: February 20, 2020
    Inventors: Christopher C. LINDSEY, Craig C. BEESON, Yuri Karl PETERSON, Rick G. SCHNELLMANN
  • METHODS FOR INDUCING MITOCHONDRIAL BIOGENESIS
    Publication number: 20140024677
    Abstract: Methods and compositions for inducing mitochondrial biogenesis are provided. In some aspects, methods for the treatment of diseases such as acute kidney disease (AKI) or a muscle wasting disease by administering tomoxetine, nisoxetine, fenoterol, formoterol, or procaterol to an individual are provided.
    Type: Application
    Filed: April 9, 2013
    Publication date: January 23, 2014
    Applicant: MUSC Foundation For Research Development
    Inventors: Rick G. SCHNELLMANN, Craig C. BEESON, Yuri K. PETERSON
  • Cell repair and regeneration by suramin and related polysulfonated napthylureas
    Patent number: 8633250
    Abstract: Disclosed herein are compositions and methods for promoting the repair and regeneration of injured tissues, such as injuries resulting from ischemic damage.
    Type: Grant
    Filed: January 11, 2007
    Date of Patent: January 21, 2014
    Assignee: MUSC Foundation for Research Development
    Inventors: Rick G. Schnellmann, Shougang Zhuang
  • Cell Repair And Regeneration By Suramin And Related Polysulfonated Naphthylureas
    Publication number: 20110034559
    Abstract: Disclosed herein are compositions and methods for promoting the repair and regeneration of injured tissues, such as injuries resulting from ischemic damage. Also disclosed are compositions and methods for accelerating wound healing in diabetic and elderly patients and inhibiting allograft failure.
    Type: Application
    Filed: August 13, 2010
    Publication date: February 10, 2011
    Inventor: Rick G. Schnellmann